drugset / Trial / NCT03271528

Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers

NCT03271528

RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a double-blind, randomized, placebo-controlled, crossover design trial tested the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this study was to determine whether lacosamide, a novel anticonvulsant that is FDA-approved for treating partial seizures, has effects on alcohol craving and consumption.

Timeline

Start
2018-04-15
Primary completion
2020-08-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 300 mg